Literature DB >> 2006796

Penetration of tumor tissue by antibodies and other immunoproteins.

T R Shockley1, K Lin, J A Nagy, R G Tompkins, H F Dvorak, M L Yarmush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2006796     DOI： 10.1111/j.1749-6632.1991.tb27257.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  [Immunotherapy of head and neck cancer. Current developments].

Authors:  P J Schuler; T K Hoffmann; T C Gauler; C Bergmann; S Brandau; S Lang
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

Review 2.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

3.  Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.

Authors:  Han-Chung Wu; De-Kuan Chang
Journal:  J Oncol       Date:  2010-05-05       Impact factor: 4.375

Review 4.  Antibody-directed targeting of the vasculature of solid tumors.

Authors:  P E Thorpe; F J Burrows
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

5.  Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.

Authors:  G Boxer; S Stuart-Smith; A Flynn; A Green; R Begent
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).

Authors:  Y Wakai; J Matsui; K Koizumi; S Tsunoda; H Makimoto; I Ohizumi; K Taniguchi; S Kaiho; H Saito; N Utoguchi; Y Tsutsumi; S Nakagawa; Y Ohsugi; T Mayumi
Journal:  Jpn J Cancer Res       Date:  2000-12

Review 7.  Vascular targeting: recent advances and therapeutic perspectives.

Authors:  Amin Hajitou; Renata Pasqualini; Wadih Arap
Journal:  Trends Cardiovasc Med       Date:  2006-04       Impact factor: 6.677

8.  Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.

Authors:  G M Boxer; A M Abassi; R B Pedley; R H Begent
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

9.  Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma.

Authors:  Ma Yan; Bao Dongmei; Zhang Jingjing; Jin Xiaobao; Wang Jie; Wang Yan; Zhu Jiayong
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.